Multiple Myeloma

被引：63

作者：

Anderson, Kenneth C.

Alsina, Melissa

Bensinger, William

Biermann, Sybil ^{[1
]}

Chanan-Khan, Asher ^{[2
]}

Cohen, Adam D. ^{[3
]}

Devine, Steven ^{[4
]}

Djulbegovic, Benjamin ^{[5
]}

Gasparetto, Cristina

Huff, Carol Ann

Jagasia, Madan ^{[6
]}

Medeiros, Bruno C.

Meredith, Ruby ^{[7
]}

Raje, Noopur ^{[8
]}

Schriber, Jeffrey ^{[9
]}

Singhal, Seema

Somlo, George ^{[10
]}

Stockerl-Goldstein, Keith

Tricot, Guido ^{[11
,12
]}

Vose, Julie M. ^{[13
]}

Weber, Donna ^{[14
]}

Yahalom, Joachim ^{[15
]}

Yunus, Furhan ^{[16
]}

机构：

[1] Fred Hutchinson Canc Res Ctr, Seattle, WA USA

[2] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA

[3] Roswell Pk Canc Inst, Buffalo, NY USA

[4] Fox Chase Canc Ctr, Philadelphia, PA USA

[5] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA

[6] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Sidney, BC, Canada

[7] Stanford Comprehens Canc Ctr, Stanford, CA USA

[8] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL USA

[9] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA

[10] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA

[11] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO USA

[12] Washington Univ, Sch Med, St Louis, MO 63130 USA

[13] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA

[14] Nebraska Med Ctr, UNMC Eppley Canc Ctr, Omaha, NE USA

[15] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[16] Mem Sloan Kettering Canc Ctr, New York, NY USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2009年 / 7卷 / 09期

关键词：

multiple myeloma; Waldenstrom's monoclonal protein; C-reactive protein; combination chemotherapy; stem cell transplant; primary amyloidosis; cytogenetics; proteasome inhibitor; immunomodulatory drugs; bisphosphonates; supportive therapies; novel therapies; STEM-CELL TRANSPLANTATION; HIGH-DOSE DEXAMETHASONE; LENALIDOMIDE PLUS DEXAMETHASONE; PEGYLATED LIPOSOMAL DOXORUBICIN; PRIMARY SYSTEMIC AMYLOIDOSIS; NATIONAL-CANCER-INSTITUTE; WALDENSTROMS MACROGLOBULINEMIA; PHASE-III; ELDERLY-PATIENTS; TREATMENT RECOMMENDATIONS;

D O I：

10.6004/jnccn.2009.0061

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Although MM is sensitive to both chemotherapy and radiation therapy, it remains incurable. However, treatment algorithms (based on published data and clinical experience) can be developed to optimize therapy, which include not only therapy for the underlying disease but also supportive therapy to enhance quality of life. Because myeloma is incurable, these guidelines prominently identify the clinical settings appropriate for treating patients enrolled in clinical research protocols. © Journal of the National Comprehensive Cancer Network.

引用

页码：908 / 942

页数：35

共 128 条

[1]

Anderson KC, 2008, J CLIN ONCOL, V26

[2]

[Anonymous], BLOOD

[3]

[Anonymous], BLOOD

[4] Single versus double autologous stem-cell transplantation for multiple myeloma [J].

Attal, M ;

Harousseau, JL ;

Facon, T ;

Guilhot, F ;

Doyen, C ;

Fuzibet, JG ;

Monconduit, M ;

Hulin, C ;

Caillot, D ;

Bouabdallah, R ;

Voillat, L ;

Sotto, JJ ;

Grosbois, B ;

Bataille, R .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (26) :2495-2502

[5] A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma [J].

Attal, M ;

Harousseau, JL ;

Stoppa, AM ;

Sotto, JJ ;

Fuzibet, JG ;

Rossi, JF ;

Casassus, P ;

Maisonneuve, H ;

Facon, T ;

Ifrah, N ;

Payen, C ;

Bataille, R .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (02) :91-97

[6] Maintenance, therapy with thalidomide improves survival in patients with multiple myeloma [J].

Attal, Michel ;

Harousseau, Jean-Luc ;

Leyvraz, Serge ;

Doyen, Chantal ;

Hulin, Cyrille ;

Benboubker, Lofti ;

Agha, Ibrahim Yakoub ;

Bourhis, Jean-Henri ;

Garderet, Laurent ;

Pegourie, Brigitte ;

Dumontet, Charles ;

Renaud, Marc ;

Voillat, Laurent ;

Berthou, Christian ;

Marit, Gerald ;

Monconduit, Mathieu ;

Caillot, Denis ;

Grobois, Bernard ;

Avet-Loiseau, Herve ;

Moreau, Philippe ;

Facon, Thierry .

BLOOD, 2006, 108 (10) :3289-3294

[7] High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions [J].

Badros, A ;

Barlogie, B ;

Morris, C ;

Desikan, R ;

Martin, SR ;

Munshi, N ;

Zangari, M ;

Toor, A ;

Cottler-Fox, M ;

Fassas, A ;

Aniassie, E ;

Schichman, S ;

Tricot, G .

BLOOD, 2001, 97 (09) :2574-2579

[8] Thalidomide and hematopoietic-cell transplantation for multiple myeloma [J].

Barlogie, B ;

Tricot, G ;

Anaissie, E ;

Shaughnessy, J ;

Rasmussen, E ;

van Rhee, F ;

Fassas, A ;

Zangari, M ;

Hollmig, K ;

Pineda-Roman, M ;

Lee, C ;

Talamo, G ;

Thertulien, R ;

Kiwan, E ;

Krishna, S ;

Fox, M ;

Crowley, J .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (10) :1021-1030

[9] Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: Final results of phase III US intergroup trial S9321 [J].

Barlogie, B ;

Kyle, RA ;

Anderson, KC ;

Greipp, PR ;

Lazarus, HM ;

Hurd, DD ;

McCoy, J ;

Dakhil, SR ;

Lanier, KS ;

Chapman, RA ;

Cromer, JN ;

Salmon, SE ;

Durie, B ;

Crowley, JC .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (06) :929-936

[10] The role of aspirin in the prevention of thrombotic complications of thalidomide and anthracycline-based chemotherapy for multiple myeloma [J].

Baz, R ;

Li, L ;

Kottke-Marchant, K ;

Srkalovic, G ;

McGowan, B ;

Yiannaki, E ;

Karam, MA ;

Faiman, B ;

Jawde, RA ;

Andresen, S ;

Zeldis, J ;

Hussein, MA .

MAYO CLINIC PROCEEDINGS, 2005, 80 (12) :1568-1574

← 1 2 3 4 5 6 7 8 9 10 →